Related Experiment Video
Updated: Mar 16, 2026

06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
9.3K
DNA Clutch Probes for Circulating Tumor DNA Analysis
Jagotamoy Das, Ivaylo Ivanov, Edward H Sargent
1Department of Biochemistry, Faculty of Medicine, University of Toronto , Toronto, Ontario, Canada M5S 3M2.
Journal of the American Chemical Society
|August 12, 2016
Summary
Researchers developed a new method for detecting circulating tumor DNA (ctDNA) without amplification. This breakthrough enables sensitive and specific identification of cancer DNA in liquid biopsies.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- Liquid biopsies offer minimally invasive disease detection.
- Analysis of circulating tumor DNA (ctDNA) is crucial for cancer diagnostics.
- Current ctDNA detection methods lack sensitivity and specificity, struggling to differentiate tumor DNA from normal DNA.
Purpose of the Study:
- To develop a novel electrochemical assay for sensitive and specific detection of mutated ctDNA.
- To overcome the challenge of distinguishing tumor-derived ctDNA from wild-type DNA in blood samples.
- To establish a non-enzymatic amplification method for ctDNA analysis.
Main Methods:
- Utilized DNA clutch probes (DCPs) to selectively expose specific ctDNA sequences.
- DCPs prevent DNA reassociation and deactivate non-target sequences.
- Employed chip-based sensors for electrochemical detection of hybridization events.
Main Results:
- Achieved highly sensitive and specific detection of mutated ctDNA.
- The assay can detect target mutations at 0.01% relative to wild-type DNA (1 fg/μL mutation vs. 100 pg/μL wild-type).
- Successfully analyzed ctDNA in samples from lung cancer and melanoma patients.
Conclusions:
- This study presents the first non-enzymatic electrochemical detection of ctDNA.
- The developed method using DCPs significantly enhances the accuracy of liquid biopsy analysis.
- This approach holds promise for improved early cancer detection and monitoring.

